A new study has shown that artificial intelligence (AI) is nearly twice as good at grading the aggressiveness of retroperitoneal sarcoma from scans as the current method. Retroperitoneal sarcoma is
A new study has shown that artificial intelligence (AI) is nearly twice as good at grading the aggressiveness of retroperitoneal sarcoma from scans as the current method. Retroperitoneal sarcoma is